Division of Experimental Pathology, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Blood. 2011 Apr 28;117(17):4658-66. doi: 10.1182/blood-2010-09-305284. Epub 2011 Mar 4.
CD36 plays a critical role in the inhibition of angiogenesis through binding to the type 1 repeats of thrombospondin-1 (TSP-1) and activating Fyn tyrosine kinase and MAPK pathways. Here, we reveal a novel association of CD36 with VEGFR-2 and spleen tyrosine kinase (Syk). We also address the correlation between the expression of CD36 and Syk by demonstrating that overexpression of CD36 in HUVECs up-regulates endogenous Syk expression. We also define a new role for TSP-1 and CD36 in the activation of the VEGFR-2 signaling pathway that requires Syk. Our findings also identify a role for Syk as a stimulator of VEGF-A-induced angiogenesis by increasing phosphorylation of Y1175 in VEGFR-2, which is a major tyrosine for promoting VEGF-A-induced endothelial cell migration. Together, these studies introduce a new signaling pathway for TSP-1, CD36, and Syk, and address the role of these proteins in regulating the angiogenic switch.
CD36 通过与血小板反应蛋白-1(TSP-1)的 type 1 重复序列结合并激活 Fyn 酪氨酸激酶和 MAPK 途径,在抑制血管生成中起着关键作用。在这里,我们揭示了 CD36 与 VEGFR-2 和脾酪氨酸激酶(Syk)的新关联。我们还通过证明在 HUVECs 中过表达 CD36 会上调内源性 Syk 表达,来探讨 CD36 和 Syk 表达之间的相关性。我们还定义了 TSP-1 和 CD36 在 VEGFR-2 信号通路激活中的新作用,该通路需要 Syk。我们的研究结果还确定了 Syk 作为 VEGF-A 诱导的血管生成的刺激物的作用,通过增加 VEGFR-2 中 Y1175 的磷酸化,该酪氨酸是促进 VEGF-A 诱导的内皮细胞迁移的主要酪氨酸。总之,这些研究为 TSP-1、CD36 和 Syk 引入了一个新的信号通路,并探讨了这些蛋白质在调节血管生成开关中的作用。